UNSPSC 51282607: Cefovecin

This classification denotes a cephalosporin antibiotic with the molecular formula C17H19N5O6S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0D1OL46ZIE, che,ically known as (7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-8-oxo-3-[(2S)-tetrahydrofuran-2-yl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid but generally known cefovecin, as which bears US NIH Compound Identifier 9578573. The term CEFOVECIN is an International Non-Proprietary Name. Most nations schedule cefovecin under HS 29419000 and SITC 54139.

As of Q4 2014, CEFOVECIN remains the US FDA Preferred Term for this commodity. Cefovecin bears US NLM identifiers UMLS ID C1869686 and NCI Concept Code C76035. SMILES: CON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C4CCCO4)C(=O)O.

UNSPSC 51282607 Cefovecin, a Commodity code, nominally designates a veterinary antibiotic, but recent state and local solicitations tagged with this code do not reflect that scope. The four most recent opportunities show state and local governments buying naloxone and drug deactivation systems, emergency medical and first aid supplies for fire-rescue operations, generic pharmaceuticals and over-the-counter products through cooperative purchasing, and exploring direct-to-manufacturer pharmacy prescription programs. The code's recent activity reflects human pharmaceutical procurement, emergency medical consumables, and pharmacy benefit innovation rather than veterinary products. Issuing bodies include county health departments, municipal fire services, state health and human services commissions, and multistate cooperative purchasing alliances. The mismatch between the code's nominal veterinary scope and the human health and pharmaceutical focus of recent opportunities suggests either systematic miscoding in state procurement systems or a code reassignment that has diverged from its original intent.

Recent opportunities span Florida, Texas, Minnesota, and Oregon. Seminole County, Florida posted an IFB on June 30, 2026 (due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries and an estimated two-year initial term. The City of Tampa released an IFB for medical and first aid supplies on March 25, 2026 (due March 13, 2026) for the Fire Department Rescue Division across 169 line items with an estimated contract value of $700,000 and a five-day delivery requirement, structured as a sheltered-market procurement for certified Small Local Business Enterprises with a 5 percent bid discount. The Texas Health and Human Services Commission issued a Request for Information on April 3, 2026 regarding direct-to-manufacturer prescription programs, signaling early-stage interest in alternative pharmacy distribution models. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) released an RFP on January 20, 2026 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products, with awards effective July 1, 2026, distributed through three authorized wholesalers and evaluation weighted 75 percent on price competitiveness. The code shows active procurement across emergency response, public health, and cooperative purchasing channels, though the veterinary-antibiotic nominal classification appears disconnected from actual buying patterns.